摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-二甲基噻吩-2,5-二羰基腈 | 155632-41-0

中文名称
3,4-二甲基噻吩-2,5-二羰基腈
中文别名
3,4-二甲基噻吩-2,5-二甲腈
英文名称
2,5-Dicyano-3,4-dimethylthiophene
英文别名
3,4-Dimethylthiophene-2,5-dicarbonitrile
3,4-二甲基噻吩-2,5-二羰基腈化学式
CAS
155632-41-0
化学式
C8H6N2S
mdl
MFCD00041438
分子量
162.215
InChiKey
KJJOQVQJRGSFGU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    122-124°C
  • 沸点:
    305.5±37.0 °C(Predicted)
  • 密度:
    1.22±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    75.8
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 安全说明:
    S22,S36/37
  • 危险类别码:
    R20/21/22
  • 海关编码:
    2934999090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险品运输编号:
    UN 3276

SDS

SDS:80fc63a751a222668ce7cbd5dd9f781c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-二甲基噻吩-2,5-二羰基腈 作用下, 以 四氯化碳 为溶剂, 反应 9.0h, 以53%的产率得到3,4-Bis(bromomethyl)-2,5-dicyanothiophene
    参考文献:
    名称:
    Synthesis of the First Thieno[3,4-c]thiophene Stabilized Only by Electronic Effects
    摘要:
    The stable, crystalline 1,3-dibromo-4,6-dicyanothieno[3,4-c]thio (3a) has been synthesized. This is the first example of a thieno[3,4-c]thiophene stabilized solely by electronic effects. The dicarbomethoxy dibromo analog 3b and the tetrabromo analog 3c were also-generated and found to be considerably less stable.
    DOI:
    10.1021/jo00087a045
  • 作为产物:
    描述:
    5-氰基-3,4-二甲基噻吩-2-羧胺氯化亚砜 作用下, 反应 2.5h, 以94%的产率得到3,4-二甲基噻吩-2,5-二羰基腈
    参考文献:
    名称:
    Synthesis and biological evaluation of novel benzimidazole derivatives and their binding behavior with bovine serum albumin
    摘要:
    A series of novel benzimidazole derivatives were synthesized and characterized by H-1 NMR, C-13 NMR, MS, IR and HRMS spectra. All the new compounds were screened for their antimicrobial activities in vitro by two-fold serial dilution technique. Bioactive assay manifested that the bis-benzimidazole derivative lid and its hydrochloride 13b exhibited remarkable antimicrobial activities, which were comparable or even better than the reference drugs Norfloxacin, Chloromycin and Fluconazole. The interaction evaluation of compound 11d with bovine serum albumin (BSA) by Fluorescence and UV-vis absorption spectroscopic method showed that BSA could generate fluorescent quenching under approximately human physiological conditions by the prepared benzimidazole compound lid as result of the formation of ground-state compound 11d BSA complex. The thermodynamic parameters indicated that the hydrogen bonds and van der Waals forces played major roles in the strong association of benzimidazole lid and BSA. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.07.015
点击查看最新优质反应信息

文献信息

  • 1,4-Hydroboration Reactions of Electron-Poor Aromatic Rings by N-Heterocyclic Carbene Boranes
    作者:Wen Dai、Steven J. Geib、Dennis P. Curran
    DOI:10.1021/jacs.0c00490
    日期:2020.4.1
    Reactions of N-heterocyclic carbene boranes (NHC-boranes) with electron poor aromatic rings under photoredox conditions provide dearomatized 3-NHC-boryl-1,5-cycohexadienes, which are formally products of 1,4-hydroboration reactions. When regioisomers are possible, the more crowded (doubly ortho-substituted) product is formed preferably or exclusively. The mechanism is thought to involve oxidation of
    N-杂环卡宾硼烷 (NHC-硼烷) 与缺电子芳环在光氧化还原条件下的反应提供脱芳构化的 3-NHC-boryl-1,5-环己二烯,它是 1,4-硼氢化反应的正式产物。当区域异构体可能时,优选或排他地形成更拥挤的(双邻位取代的)产物。该机制被认为涉及 NHC-硼烷氧化为 NHC-硼基自由基,将缺电子芳环还原为自由基阴离子,自由基与自由基阴离子偶联生成环己二烯基阴离子,最后进行区域选择性质子化。
  • AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS
    申请人:Cadieux Jean-Jacques
    公开号:US20100240713A1
    公开(公告)日:2010-09-23
    This invention is directed to compounds of formula (I), wherein m, formula (II), R 1 , R 2 and R 3 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment of iron disorders. This invention is also directed to pharmaceutical compositions comprising the compounds and methods of using the compounds to treat iron disorders.
    本发明涉及式(I)的化合物,其中m、式(II)、R1、R2和R3如本文所定义,作为立体异构体、对映异构体、互变异构体或其混合物;或其药学上可接受的盐、溶剂或前药,用于治疗铁代谢紊乱。本发明还涉及包含该化合物的制药组合物以及使用该化合物治疗铁代谢紊乱的方法。
  • Beye Norbert, Cava Michael P., J. Org. Chem, 59 (1994) N 8, S 2223-2226
    作者:Beye Norbert, Cava Michael P.
    DOI:——
    日期:——
  • [EN] AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS<br/>[FR] COMPOSÉS AROMATIQUES ET HÉTÉROAROMATIQUES UTILES DANS LE TRAITEMENT DE TROUBLES DU MÉTABOLISME DU FER
    申请人:XENON PHARMACEUTICALS INC
    公开号:WO2008151288A2
    公开(公告)日:2008-12-11
    [EN] This invention is directed to compounds of formula (I), wherein m, formula (II), R1, R2 and R3 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment of iron disorders. This invention is also directed to pharmaceutical compositions comprising the compounds and methods of using the compounds to treat iron disorders.
    [FR] La présente invention concerne des composes de formule (I), dans laquelle m, formule (II), R1, R2 et R3 sont tels que définis dans la description, sous forme d'un stéréoisomère, énantiomère, tautomère de ceux-ci ou leurs mélanges ; ou un sel, solvate ou promédicament pharmaceutiquement acceptable de ceux-ci, pour le traitement de troubles du métabolisme du fer. L'invention concerne également des compositions pharmaceutiques comportant les composés et des procédés d'utilisation des composés pour traiter des troubles du métabolisme du fer.
  • Synthesis and biological evaluation of novel benzimidazole derivatives and their binding behavior with bovine serum albumin
    作者:Shao-Lin Zhang、Guri L.V. Damu、Ling Zhang、Rong-Xia Geng、Cheng-He Zhou
    DOI:10.1016/j.ejmech.2012.07.015
    日期:2012.9
    A series of novel benzimidazole derivatives were synthesized and characterized by H-1 NMR, C-13 NMR, MS, IR and HRMS spectra. All the new compounds were screened for their antimicrobial activities in vitro by two-fold serial dilution technique. Bioactive assay manifested that the bis-benzimidazole derivative lid and its hydrochloride 13b exhibited remarkable antimicrobial activities, which were comparable or even better than the reference drugs Norfloxacin, Chloromycin and Fluconazole. The interaction evaluation of compound 11d with bovine serum albumin (BSA) by Fluorescence and UV-vis absorption spectroscopic method showed that BSA could generate fluorescent quenching under approximately human physiological conditions by the prepared benzimidazole compound lid as result of the formation of ground-state compound 11d BSA complex. The thermodynamic parameters indicated that the hydrogen bonds and van der Waals forces played major roles in the strong association of benzimidazole lid and BSA. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

香薷二醇 顺式-1-(2-呋喃基)-1-戊烯 顺-1,2-二氰基-1,2-双(2,4,5-三甲基-3-噻吩基)乙烯 顺-1,2-(2-噻嗯基)二乙烯 雷尼替丁-N,S-二氧化物 雷尼替丁-N-氧化物 西拉诺德 螺[环氧乙烷-2,3'-吡咯并[1,2-a]吡嗪] 萘并[2,1,8-def]喹啉 苯硫基溴化镁 苯甲酸,2-[[[7-[[(3.β.)-3-羟基-28-羰基羽扇-20(29)-烯-28-基]amino]庚基]氨基]羰基] 苍术素 缩水甘油糠醚 紫苏烯 糠醛肟 糠醇-d2 糠醇 糠基硫醇-d2 糠基硫醇 糠基甲基硫醚 糠基氯 糠基氨基甲酸异丙酯 糠基丙基醚 糠基丙基二硫醚 糠基3-巯基-2-甲基丙酸酯 糠基-异戊基醚 糠基-异丁基醚 糠基 2-甲基-3-呋喃基二硫醚 磷杂茂 硫酸异丙基糠酯 硫代磷酸O-糠基O-甲基S-(2-丙炔基)酯 硫代磷酸O-乙基O-糠基S-(2-丙炔基)酯 硫代甲酸S-糠酯 硫代噻吩甲酰基三氟丙酮 硫代乙酸糠酯 硫代丙酸糠酯 硅烷,三(1-甲基乙基)[(3-甲基-2-呋喃基)氧代]- 硅烷,(1,1-二甲基乙基)(2-呋喃基甲氧基)二甲基- 砷杂苯 甲酸糠酯 甲氧亚胺基呋喃乙酸铵盐 甲基糠基醚 甲基糠基二硫 甲基呋喃-2-基甲基氨基甲酸酯 甲基丙烯酸糠酯 甲基5-(羟基甲基)-2-呋喃甲亚氨酸酯 甲基(2Z)-3-甲基-2-(甲基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-氨基-2-(甲基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-异丙基-2-(异丙基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2-甲基-3-呋喃基)二硫